Trial Identifier: | D4194R00004 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04068168 |
Start Date: | January 2020 |
Primary Completion Date: | February 2025 |
Study Completion Date: | February 2025 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |
South Korea | Seoul, South Korea |